Skip to main content

Table 2 Demographic Information for the 46 Included Articles

From: Evaluating Fidelity of reporting in randomized controlled trials on childhood acute lymphocytic leukemia

Demographic

Article %

Funding source

 private

50.0% (23/46)

 public

43.5% (20/46)

 not mentioned/other

21.7% (10/46)

 industry

10.9% (5/46)

 hospital

4.3% (2/46)

 Study design

 parallel arm

73.7% (35/46)

 crossover

13.0% (6/46)

 factorial

8.7% (4/46)

 Intervention

 pharmacological

76.1% (35/46)

 non-pharmacological

23.9% (11/46)

Blinding

 no blinding/not specified

69.6% (32/46)

 double-binded

21.7% (10/46)

 single-blinded

8.7% (4/46)

Stated adherence to TIDieR

 no

100% (46/46)

 yes

0% (0/46)